1st Quarter - Report
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
Income
—
Expenses
$40,288
Expense method
C: businesses, Internal Revenue Code section 162(e)
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY09 Agriculture Appropriations and FY09 Homeland Security Appropriations related to proposals limiting FDA authority to regulate pharmaceutical imports
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT D FRANKS | Member of Congress 1992-2000 |
| STEVE ISSENMAN | — |
| SARAH G KAN | Staff Member 1999-2002 |
Trade (domestic/foreign) TRD
Issues relating to importation of prescription drugs and intellectual property protections.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT D FRANKS | Member of Congress 1992-2000 |
| STEVE ISSENMAN | — |
| SARAH G KAN | Staff member 1999-2002 |
Copyright/Patent/Trademark CPT
S 1182 Patent Reform Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT D FRANKS | Member of Congress 1992-2000 |
| STEVE ISSENMAN | — |
| SARAH G KAN | Staff Member 1999-2002 |
Health Issues HCR
To promote the better understanding of the pharmaceutical and medical device industry in New Jersey.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT D FRANKS | Member of Congress 1999-2002 |
| STEVE ISSENMAN | — |
| SARAH G KAN | Staff member 1999-2002 |
Medicare/Medicaid MMM
Medicare Reform Package
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT D FRANKS | Member of Congress 1992-2000 |
| STEVE ISSENMAN | — |
| SARAH G KAN | Staff Member 1999-2002 |
Environment/Superfund ENV
Pharmaceuticals in the Environment
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVE ISSENMAN | — |
| SARAH G KAN | Staff Member 1999-2002 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.